PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade.

Volume:Pages
38(13):110582
Site
Toronto
Pubmed id
35354055
Authors

Srour N, Villarreal OD, Hardikar S, Yu Z, Preston S, Miller WH, Szewczyk MM, Barsyte-Lovejoy D, Xu H, Chen T, Del Rincón SV, Richard S

DOI
10.1016/j.celrep.2022.110582
Journal
Cell Rep
Publication Date
2022-3-29
Year
2022
N Publication Date
PI authors
Barsyte-Lovejoy
Validated
Y